Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 72516-035

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 72516-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wellbutrin Chemical Structure (Bupropion Er Tablets Xl 1)

Chemical structure of bupropion hydrochloride, showing the molecular arrangement including a chlorine-substituted aromatic ring and associated functional groups.*

FDA Label Image

Bupropion Hydrochloride Extended-release Tablets (xl), 300 mg, 30 Count (Bupropion Er Tablets Xl 2)

Label for buPropion Hydrochloride XL 300 mg extended-release tablets by Oryza Pharmaceuticals Inc. The label includes the NDC 72516-036-03, specifies 30 tablets per bottle, and highlights a warning about not combining with Zyban or similar medicines. Pharmacists are instructed to dispense a Medication Guide separately.*

FDA Label Image

Bupropion Hydrochloride Extended-release Tablets (xl), 300 mg, 90 Count (Bupropion Er Tablets Xl 3)

Label for buPropion Hydrochloride XL 300 mg extended-release oral tablets by Oryza Pharmaceuticals Inc. The label states 'Once-Daily', contains 90 tablets, and includes a warning not to use with Zyban or other bupropion hydrochloride medicines. It instructs pharmacists to dispense a Medication Guide to patients. The label also shows a barcode and manufacturing details.*

FDA Label Image

Bupropion Hydrochloride Extended-release Tablets (xl), 300 mg, 500 Count (Bupropion Er Tablets Xl 4)

Label for buPropion Hydrochloride XL Extended-Release Tablets (XL) 300 mg by Oryza Pharmaceuticals Inc. The label indicates the product is for once-daily oral use, prescription only, with a package count of 500 tablets. It includes warnings, storage instructions, and a request for pharmacists to dispense the Medication Guide separately. The label also features a barcode and manufacturer details.*

FDA Label Image

Bupropion Hydrochloride Extended Release Tablets, 150 mg, 30 Tablets (Bupropion Er Tablets Xl 5)

Label of buPropion Hydrochloride XL 150 mg extended-release tablets by Oryza Pharmaceuticals Inc. The label indicates once-daily oral dosage, contains 30 tablets, and includes warnings to not use with Zyban or similar bupropion products. It instructs pharmacists to dispense a separate Medication Guide. Storage and manufacturer details are also present.*

FDA Label Image

Bupropion Hydrochloride Extended Release Tablets, 150 mg, 90 Tablets (Bupropion Er Tablets Xl 6)

Label for buPropion Hydrochloride XL 150 mg extended-release tablets by Oryza Pharmaceuticals Inc., containing 90 tablets. The label includes a barcode, NDC 72516-035-09, and warnings against use with Zyban or other bupropion hydrochloride medicines. It instructs pharmacists to dispense a Medication Guide separately to each patient. Additional manufacturing and storage information is printed on the label.*

FDA Label Image

Bupropion Hydrochloride Extended Release Tablets, 150 mg, 500 Tablets (Bupropion Er Tablets Xl 7)

Label for buPropion Hydrochloride XL 150 mg Extended-Release Tablets, once-daily oral tablets. The label features dosage instructions, a warning against use with Zyban or other bupropion hydrochloride medicines, and a note for pharmacists to dispense the Medication Guide separately. The product is manufactured by Oryza Pharmaceuticals Inc. and the package contains 500 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.